Sunday, August 14, 2022

29 Percent of Young Pfizer COVID Vaccine Recipients Suffered Heart Effects: Study

Nearly three in 10 children who received Pfizer’s COVID-19 vaccine experienced heart effects afterwards, according to a new study.

Researchers studied 301 students across two schools in Thailand. The students were aged 13 to 18 and had received a dose of Pfizer’s vaccine without a serious adverse event. Most had no underlying disease, while 44 had conditions such as asthma and allergic rhinitis.

Researchers conducted laboratory tests to establish a baseline and followed up at three days, seven days, and 14 days after the students received a second dose of the vaccine.

Researchers found that 29 percent of the youth experienced cardiovascular effects, including heart palpitations, chest pain, and shortness of breath. Fifty-four had abnormal electrocardiogram results. Six experienced mitral valve prolapse, which the Mayo Clinic describes as a heart valve disease; six had high blood pressure, and seven were diagnosed with heart inflammation.

Two of the children were hospitalized, with one being admitted to intensive care.

Limitations of the study, published ahead of peer review and funded by Mahidol University, included requiring parental permission for blood testing, which could have impacted participation.

Nearly 100 percent of the vaccine recipients recovered within two weeks, researchers said. Still, due to the detection of heart effects, young people receiving any of the vaccines based on messenger RNA technology—both the Pfizer and Moderna vaccines are—”should be monitored for side effects,” the authors said.

Pfizer did not respond to a request for comment.


Several cardiologists, after reviewing the new paper, said it adds to the body of evidence that the risks of the vaccines may outweigh the benefits, especially for young people.

“Any form of heart damage in young persons is concerning since the long-term risks of heart failure and sudden death with exercise are unknown,” Dr. Peter McCullough, the chief medical adviser for the Truth for Health Foundation, told The Epoch Times in an email.

“This is one of ~200 published papers demonstrating the risks of COVID-19 vaccination far outweigh any theoretical benefit,” he added.

U.S. authorities have acknowledged a link between the Pfizer and Moderna vaccines and heart inflammation, but maintain that the benefits of the shots outweigh the risks for all age groups beyond six months old. According to reports to the U.S. Vaccine Adverse Event Reporting System through May 26, males aged 5 to 49, and females aged 12 to 29, had higher-than-background rates of myocarditis following a second Pfizer dose. The highest rate was 76 per million within seven days of a second dose among males 16 or 17 years old.

Dr. Anish Koka, a cardiologist in Philadelphia, said the new study results “are not reassuring.” While the study authors said most patients recovered, some of the conditions they experienced are far from mild, Koka wrote in a blog post.

“The Thai study helps fill in some of the data void so parents and their doctors can be better informed when discussing the risks and benefits of the vaccines,” he said.


Game-changing new test and treatment for Long Covid

Australian scientists are a step closer to a test and treatment for long Covid, after determining it causes the same biological impairments as chronic fatigue syndrome.

The ground breaking findings, by Griffith University researchers, could significantly help the 500,000 Australians estimated to be battling the condition.

Long Covid is a collection of symptoms including extreme fatigue (tiredness), shortness of breath, heart palpitations, chest pain or tightness that continue more than 12 weeks after a Covid infection, and can be severe enough to prevent a person working or living normal life.

Professor Sonya Marshall-Gradisnik, who is behind the research which will be published the Journal of Molecular Medicine on Thursday, has already developed a diagnostic test for chronic fatigue syndrome and identified potential treatments.

“The receptors that we have identified previously as being faulty or dysfunctional in ME/CFS (chronic fatigue syndrome) patients have the same dysfunction in those long Covid patients we’ve examined,” she said.

“Patients with long Covid report neurocognitive, immunologic, gastrointestinal, and cardiovascular manifestations, which are also symptoms of ME/CFS,” Professor Marshall-Gradisnik said.

Her research team has been working on chronic fatigue syndrome for more than a decade and has identified a family of receptors that are dysfunctional in patients suffering ME/CFS.

They found patients with the syndrome had lower levels of calcium coming into their cells, and that their cells stored less calcium, and this was the basis of their illness.

“These channels allow ions such as calcium to flow in and out of cells, and thereby control many different biological processes,” she said.

“Patients can experience different symptoms depending on which cells in the body are affected – from brain fog and muscle fatigue to possible organ failure.”

Blood tests performed in Professor Marshall-Gradisnik’s laboratory show people with long Covid have the same damage to these receptors as patients with ME/CFS.

“Calcium is like the Goldilocks molecule. It is like the most important molecule you can have. It causes muscle contraction and causes brain activity. It’s very much critical in all cell functions,” she said.

A significant proportion of people who develop ME/CFS do so following a virus so it is thought these receptors are activated by viruses and, of course, patients that have long Covid had a viral assault, Professor Marshall-Gradisnik said.

Her team has already developed a diagnostic blood test for the ME/CFS that also has the potential to be used in long Covid patients. It is being refined so it can be done in hours, not days.

The team is also testing a range of available medical treatments that worked on calcium channels to see if they may be a possible treatment.

They found the drug Naltrexone at a very low dose of 0.5 milligrams to five milligrams stopped the obstruction of the opioid receptor on the calcium channel, allowing it to function again.

Professor Marshall-Gradisnik said taking calcium supplements was not of any use.

“It’s not what you ingest, it is how calcium gets processed and gets into the cell that matters,” she said.

There have been more than 9.5 million cases of Covid reported in Australia and five per cent, or around 475,000, of these patients are expected to be left with long-term illness.


CDC Admits It Gave False Information About COVID-19 Vaccine Surveillance

The U.S. Centers for Disease Control and Prevention (CDC) is admitting it gave false information about COVID-19 vaccine surveillance, including inaccurately saying it conducted a certain type of analysis over one year before it actually did.

The false information was conveyed in responses to Freedom of Information Act (FOIA) requests for the results of surveillance, and after the CDC claimed COVID-19 vaccines are being monitored “by the most intense safety monitoring efforts in U.S. history.”

“CDC has revisited several FOIA requests and as a result of its review CDC is issuing corrections for the following information,” a CDC spokeswoman told The Epoch Times in an email.

No CDC employees intentionally provided false information and none of the false responses were given to avoid FOIA reporting requirements, the spokeswoman said.

Heart Inflammation

The Epoch Times in July submitted a FOIA, or a request for non-public information, to the CDC for all reports from a team that was formed to study post-vaccination heart inflammation by analyzing reports submitted to the Vaccine Adverse Event Reporting System (VAERS), a system run by the CDC and the U.S. Food and Drug Administration.

The CDC not only said that the team did not conduct any abstractions or reports through October 2021, but that “an association between myocarditis and mRNA COVID-19 vaccination was not known at that time.”

That statement was false.

Clinical trials of the Pfizer and Moderna COVID-19 vaccines detected neither myocarditis nor pericarditis, two types of heart inflammation. But by April 2021, the U.S. military was raising the alarm about post-vaccination heart inflammation, and by June 2021, the CDC was publicly acknowledging a link.

The CDC previously corrected the false statement but did not say whether its teams had ever analyzed VAERS reports.

“In reference to myocarditis abstraction from VAERS reports—this process began in May 2021 and continues to this date,” the CDC spokeswoman said in an email.

The CDC has still not released the results of analyses.

Data Mining

The CDC promised in January 2021 that it would perform a specific type of data mining analysis on VAERS reports called Proportional Reporting Ratio (PRR). But when Children’s Health Defense, a nonprofit, asked for the results, the CDC said that “no PRRs were conducted by the CDC” and that data mining “is outside of th[e] agency’s purview.”

Asked for clarification, Dr. John Su, who heads the CDC’s VAERS team, told The Epoch Times in an email that the CDC started performing PRRs in February 2021, “and continues to do so to date.”

The CDC is now saying that both the original response and Su’s statement were false.

The agency didn’t start performing PRRs until March 25, 2022, the CDC spokeswoman said. The agency stopped performing them on July 31, 2022.

The spokeswoman said it “misinterpreted” both Children’s Health Defense and The Epoch Times.

Children’s Health Defense had asked for the PRRs the CDC had performed from Feb. 1, 2021, through Sept. 30, 2021. The Epoch Times asked if the response to the request was correct.

The spokeswoman said the CDC thought “data mining” referred only to Empirical Bayesian (EB) data mining, a different type of analysis that the Food and Drug Administration has promised to perform on VAERS data.

“The notion that the CDC did not realize we were asking about PRRs but only data mining in general is simply not credible, since our FOIA request specifically mentioned PRRs and their response also mentioned that they did not do PRRs. They did not say ‘data mining in general,'” Josh Guetzkow, a senior lecturer at The Hebrew University of Jerusalem who has been working with Children’s Health Defense, told The Epoch Times via email.

“There is also no credible reason why they waited until March 25, 2022, to calculate PRRs, unless it was in response to our initial FOIA filed in December 2021, which was rejected on March 25, 2022—shortly after they say they began their calculations. It means the CDC was not analyzing VAERS for early warning safety signals for well over a year after the vaccination campaign began—which still counts as a significant failure,” he added.

The CDC has also not released the results of the PRRs. “PRR results were generally consistent with EB data mining, revealing no additional unexpected safety signals. Given it is a more robust data mining technique, CDC will continue relying upon EB data mining at this time,” the agency spokeswoman said.

The FDA has told The Epoch Times it conducted EB data mining but the agency has declined to share the results.




No comments: